Compound Care Pharmacy

FDA inspection history in Louisville, Kentucky, 2019

1
Form 483

Every document, by year

  • Form 483

2019: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019One Form 483, at Louisville, Kentucky.

Cited most

Across all Compound Care Pharmacy observations on file

  • 21 CFR 211.113
    Control of microbiological contamination
    1
  • 21 CFR 211.165
    Testing and release for distribution
    1
  • 21 CFR 211.84
    Testing and approval or rejection of components, drug product containers, and closures
    1

The complete Compound Care Pharmacy file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2019-05-16483 Form 483$99

Investigators on these documents

Adam R. Cooke (1)

FEI number 3006269306 · most recent document May 16, 2019

About Compound Care Pharmacy

How many FDA Form 483s has Compound Care Pharmacy received?

FDA Intel has 1 Form 483 on file for Compound Care Pharmacy; the most recent is dated May 16, 2019.

When was Compound Care Pharmacy last inspected by FDA?

The most recent FDA inspection document on file for Compound Care Pharmacy is a Form 483 dated May 16, 2019, for the site in Louisville, Kentucky.

What did FDA cite at Compound Care Pharmacy?

The regulations cited most in the observations on file for Compound Care Pharmacy are 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.165 (Testing and release for distribution), 1 time; 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 1 time.